Omalizumab (Xolair) is a recombinant DNA-derived humanized IgG1k monoclonal antibody that binds human immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic asthma and Chronic Idiopathic Urticaria (CIU). Omalizumab inhibits t
* VAT and and shipping costs not included. Errors and price changes excepted